Lisa K. Lee

Dr. Lisa K. Lee


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
LLLisa K. Lee
Lisa K. Lee
LMLejla Medzikovic
Lejla Medzikovic
MEMansoureh Eghbali
Mansoureh Eghbali
HEHolger K. Eltzschig
Holger K. Eltzschig
XYXiaoyi Yuan
Xiaoyi Yuan
Acute respiratory distress syndrome (ARDS) is a significant cause of morbidity and mortality in the intensive care unit (ICU) and is characterized by lung epithelial and endothelial cell injury, with increased permeability of the alveolar-capillary membrane, leading to pulmonary edema, severe hypoxia, and difficulty with ventilation. The most common cause of ARDS is sepsis, and currently, treatment of ARDS and sepsis has consisted mostly of supportive care because targeted therapies have largely been unsuccessful. The molecular mechanisms behind ARDS remain elusive. Recently, a number of microRNAs (miRNAs) identified through high-throughput screening studies in ARDS patients and preclinical animal models have suggested a role for miRNA in the pathophysiology of ARDS. miRNAs are small noncoding RNAs ranging from 18 to 24 nucleotides that regulate gene expression via inhibition of the target mRNA translation or by targeting complementary mRNA for early degradation. Unsurprisingly, some miRNAs that are differentially expressed in ARDS overlap with those important in sepsis. In addition, circulatory miRNA may be useful as biomarkers or as targets for pharmacologic therapy. This can be revolutionary in a syndrome that has neither a measurable indicator of the disease nor a targeted therapy. While there are currently no miRNA-based therapies targeted for ARDS, therapies targeting miRNA have reached phase II clinical trials for the treatment of a wide range of diseases. Further studies may yield a unique miRNA profile pattern that serves as a biomarker or as targets for miRNA-based pharmacologic therapy. In this review, we discuss miRNAs that have been found to play a role in ARDS and sepsis, the potential mechanism of how particular miRNAs may contribute to the pathophysiology of ARDS, and strategies for pharmacologically targeting miRNA as therapy.

3 October 2018 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
LLLisa K. Lee
Lisa K. Lee
MBMarsha Kristel L. Bernardo
Marsha Kristel L. Bernardo
TGTristan R. Grogan
Tristan R. Grogan
DEDavid A. Elashoff
David A. Elashoff
WRWendy H. P. Ren
Wendy H. P. Ren

17 April 2023 in British Journal of Anaesthesia
Verified
Journal Article
Open access
AGAnnery G Garcia-Marcinkiewicz
Annery G Garcia-Marcinkiewicz
LLLisa K. Lee
Lisa K. Lee
BHBishr Haydar
Bishr Haydar
JFJohn E Fiadjoe
John E Fiadjoe
CMClyde T Matava
Clyde T Matava
PCPeDI Collaborative
PeDI Collaborative
Difficult facemask ventilation is perilous in children whose tracheas are difficult to intubate. We hypothesised that certain physical characteristics and anaesthetic factors are associated with difficult mask ventilation in paediatric patients who also had difficult tracheal intubation. We queried a multicentre registry for children who experienced "difficult" or "impossible" facemask ventilation. Patient and case factors known before mask ventilation attempt were included for consideration in this regularised multivariable regression analysis. Incidence of complications, and frequency and efficacy of rescue placement of a supraglottic airway device were also tabulated. Changes in quality of mask ventilation after injection of a neuromuscular blocking agent were assessed. The incidence of difficult mask ventilation was 9% (483 of 5453 patients). Infants and patients having increased weight, being less than 5th percentile in weight for age, or having Treacher-Collins syndrome, glossoptosis, or limited mouth opening were more likely to have difficult mask ventilation. Anaesthetic induction using facemask and opioids was associated with decreased risk of difficult mask ventilation. The incidence of complications was significantly higher in patients with "difficult" mask ventilation than in patients without. Rescue placement of a supraglottic airway improved ventilation in 71% (96 of 135) of cases. Administration of neuromuscular blocking agents was more frequently associated with improvement or no change in quality of ventilation than with worsening. Certain abnormalities on physical examination should increase suspicion of possible difficult facemask ventilation. Rescue use of a supraglottic airway device in children with difficult or impossible mask ventilation should be strongly considered.

1 April 2017 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
PDF file
MIMarc Iravani
Marc Iravani
LLLisa K. Lee
Lisa K. Lee
MCMaxime Cannesson
Maxime Cannesson

22 December 2018 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
LLLisa K. Lee
Lisa K. Lee
MWMichelle Y. Woodfin
Michelle Y. Woodfin
MVMarissa G. Vadi
Marissa G. Vadi
TGTristan R. Grogan
Tristan R. Grogan
PRPhillip J. Ross
Phillip J. Ross
MIMarc Iravani
Marc Iravani
Although patent ductus arteriosus (PDA) ligations in the Neonatal Intensive Care Unit (NICU) have been an accepted practice, many are still performed in the Operating Room (OR). Whether avoiding transport leads to improved perioperative outcomes is unclear. Here we aimed to determine whether PDA ligations in the NICU corresponded to higher risk of surgical site infection or mortality and if transport was associated with worsened perioperative outcomes. We performed a retrospective cohort study of NICU patients, ≤37 weeks post-menstrual age, undergoing surgical PDA ligation in the NICU or OR. We excluded any infants undergoing device PDA closure. We measured the incidence of perioperative hypothermia, cardiac arrest, decreases in SpO2, hemodynamic instability and postoperative surgical site infection, sepsis and mortality. Data was collected on 189 infants (100 OR, 89 NICU). After controlling for number of preoperative comorbidities, weight at time of procedure, procedure location and hospital in the mixed-effect model, no significant difference in mortality or sepsis was found (odds ratio 0.31, 95%CI 0.07, 1.30; p = 0.107, and odds ratio 0.40; 95%CI 0.14, 1.09; p = 0.072, respectively). There was an increased incidence of hemodynamic instability on transport postoperatively in the OR group (12.4% vs 2%, odds ratio 6.93; 95% CI 1.48, 35.52; p = 0.014). PDA ligations in the NICU were not associated with higher incidences of surgical site infection or mortality. There was an increased incidence of hemodynamic instability in the OR group on transport back to the NICU. Larger multicenter studies following long-term outcomes are needed to evaluate the safety of performing all PDA ligations in the NICU. Patent ductus arteriosus, Newborn infant, Neonatal intensive care unit, Surgical wound infection, Postoperative period, Hemodynamics

29 May 2025 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
MBMartina Bordini
Martina Bordini
LOLuca Orsini
Luca Orsini
SLSimon Y.W. Li
Simon Y.W. Li
JOJulia Olsen
Julia Olsen
MSMary Lyn Stein
Mary Lyn Stein
KMKelsey Mitchell
Kelsey Mitchell